Option Care Health OPCH
Revenue per employee
8,266 employees as of 2025/FY (+2.2% YoY). Revenue per employee is total revenue divided by headcount — a rough productivity gauge, not a per-worker pay figure.
Management team
Background
Mr. John Charles Rademacher, Director, President and Chief Executive Officer. Experience: President and Chief Executive Officer, Option Care Health (2018-Present), Chief Operating Officer, Option Care Health (2015-2018), President, Ambulatory Care (2012-2014) and President, Nuclear & Pharmacy Services (2007-2012) of Cardinal Health, Inc., a publicly-traded multinational health care services company and Senior Vice President of Cigna, a publicly-traded health services company (2001-2007). Mr. Rademacher is on the board of directors of Thrivent Financial for Lutherans, a privately-held Fortune 500 financial services company.
Background
Mr. Luke Whitworth, Chief Operating Officer (since January 2023); Responsible for leading our operations, including pharmacy, nursing, nutrition, patient registration and revenue cycle management teams Previously served as our Senior Vice President, Specialty Operations & Patient Administration (August 2022-January 2023); Senior Vice President, Revenue Cycle Management (October 2019-August 2022); and Vice President, Operational Excellence and Revenue Cycle Management (April 2018-October 2019); Nearly 15 years at Cardinal Health in roles of increasing responsibility across sales and general management, corporate development and finance Holds a B.S.B.A. in Finance from The Ohio State University and an M.B.A. in General Management from the Stephen M. Ross School of Business at the University of Michigan.
Background
Mr. Collin G. Smyser, General Counsel and Corporate Secretary (since April 2022); Responsible for overseeing our legal, compliance and public policy functions Previous roles at Elanco Animal Health, a publicly-traded global leader in the animal health pharmaceutical industry (October 2021-April 2022); Kimberly-Clark Corporation, a publicly-traded global consumer products manufacturer (February 2018-October 2021); and Walgreens Boots Alliance, Inc., a publicly-traded global integrated healthcare, pharmacy and retail company (March 2015-February 2018); Began his career in private practice at Allen & Overy LLP in London, England and Winston & Strawn LLP in Chicago, Illinois; Holds a B.A. and M.A. in economics from the University of Southern California and a J.D. from Stanford Law School.
Background
Ms. Meenal A. Sethna, serves as Chief Financial Officer at company. She is Responsible for leading our finance, accounting, treasury, investor relations, and information technology functions. Previous roles at Littelfuse, Inc. (2016-September 2025); Illinois Tool Works Inc; Motorola Inc.; and Baxter Certified public accountant in Illinois . Holds a B.A. from the University of Illinois-Urbana and an M.B.A. from the Kellogg School of Management at Northwestern University and Serves on the board of directors of SPX Technologies, Inc.; chair of the audit committee and a member of the governance & sustainability committee.
Background
Mr. Harry M. Jansen Kraemer, Jr, Chairman of the Board. Experience: Clinical Professor of Management and Strategy at the Kellogg School of Management at Northwestern University (2005-Present), Executive Partner of MDP, a private equity firm (2005-2025) and Chairman (2000-2004), President (1997-2004), Certified Public Accountant and Chief Executive Officer (1999-2004) of Baxter International Inc., a global, publicly-traded manufacturer of diagnostic and other health care-related products (Baxter). He serves on Other U.S. Public Company Boards like Leidos Holdings, Inc. (1997-Present).Former U.S. Public Company Boards (within last five years) DENTSPLY Sirona Inc.
Background
Mr. R. Carter Pate serves as Independent Director at company. Experiences includes Chief Executive Officer, Modivcare Inc., a global holding company whose subsidiaries provide technology-enabled healthcare logistics and other services (2017-2020), Chief Executive Officer, MV Transportation, Inc., a passenger transportation company (2011-2014) and Global and U.S. Managing Partner, Health Care and Government Services Practice, PricewaterhouseCoopers (1996-2012), Other U.S. Public Company Boards Purple Innovation, Inc. (2023-Present)
Background
Dr. Natasha Deckmann, Independent Director. Experience: Chief Executive Officer (2025-Present), President (2024-2025) and Chief Transformation Officer (2024) of Tivity Health, Inc., a leading, national provider of health and well-being solutions designed to support healthier, more active lives, Chief Operating Officer, Chief Clinical Officer, and Board Member of SecureSeniorConnections, a health care technology and services business (2020-2023), Chief Executive Officer of CarePoint Health System, a three hospital and two medical group system in New Jersey (2018-2020), Senior Vice President, Population Health Solutions and Chief Operating Officer, Consumer Solutions Group, Optum, a UnitedHealth Group company (2013-2018) and Positions of increasing responsibility at Marsh Inc., a global insurance broker and risk advisor (2006-2012), including as Chief Operating Officer of Marsh International. Former U.S. Public Company Boards (within last five years) Senior Connect Acquisition Corp. I.
Background
Mr. Norman L. Wright serves as Independent Director at company. Experience includes Positions of increasing responsibility at UnitedHealth, including as EVP, Health Equity Strategy (2022-2023); EVP and Chief Customer Experience Officer (2021-2022); EVP, Chief Marketing and Customer Experience Officer, Optum (2019-2021); and SVP and Chief of Global Operations (2013-2016), Positions of increasing responsibility at UnitedHealth, including as EVP, Health Equity Strategy (2022-2023); EVP and Chief Customer Experience Officer (2021-2022); EVP, Chief Marketing and Customer Experience Officer, Optum (2019-2021); and SVP and Chief of Global Operations (2013-2016) and Other U.S. Public Company Boards First Solar, Inc. (2022-Present)
Background
Mr. Eric K. Brandt, Independent Director. Experience Chief Financial Officer of Broadcom Inc., a Fortune 500 technology company (2007-2016), President and Chief Executive Officer of Avanir Pharmaceuticals, Inc., a pharmaceutical manufacturing company (2005-2007), Positions of increasing responsibility at Allergan Inc, a publicly-traded pharmaceutical manufacturing company, including as its Chief Financial Officer (1999-2005) and Vice President and Partner, The Boston Consulting Group, Inc. (1989-1999). He serves on Other U.S. Public Company Boards Nutanix, Inc. (2025-Present), Gen Digital Inc. (2020-Present) and Lam Research Corporation (2010-Present). Former U.S. Public Company Boards (within last five years) DENTSPLY Sirona, The Macerich Company and Inc. Altaba Inc.
Background
Ms. Barbara W. Bodem served as Interim Chief Financial Officer of DENTSPLY Sirona Inc., a publicly-traded manufacturer of professional dental products and technologies (May 2022-October 2022). Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, Inc., a medical device and technology provider (2018-2021), Senior Vice President, Finance, of Mallinckrodt plc, a global specialty pharmaceutical company (2015-2018), Vice President, Global Commercial Finance of Hospira, a global pharmaceutical and medical device company (2013-2015), She serves on Other U.S. Public Company Boards BioMarin Pharmaceutical Inc. (2023-Present), Enovis Corporation (2022-Present) and Former U.S. Public Company Boards (within last five years) Syneos Health, Inc. and Turning Point Therapeutics, Inc.
Background
Ms. Elizabeth D. Bierbower, Independent Director. Experience Chairman and Chief Executive Officer of Friday Health Plans, a health insurance company (2022-2023); Ms. Bierbower worked with the insurance department of each applicable state to transition the operations of Friday Health Plans into receivership and Various leadership roles at Humana, a leading health insurance company, including as Segment President (2018-2020), President of Employer Group Segment (2012-2018); Chief Operating Officer of Specialty Benefits (2008-2012); and Vice President of Product Innovation (2001-2008). She serves on Other U.S. Public Company Boards Progyny, Inc. (2025-Present).
Background
Timothy Sullivan has served on our Board since 2019, and served on the legacy Option Care board from 2015 until the Merger. Mr. Sullivan is a founder and Managing Director of MDP, which specializes in management buyouts and special equity investing and manages over 18 billion dollars of committed capital and portfolio investments. Mr. Sullivan is also the Head of Madison Dearborn Partners' Health Care team. Prior to co-founding MDP in 1993, Mr. Sullivan was with First Chicago Venture Capital for four years after having served in the U.S. Navy. Mr. Sullivan concentrates on investments in the health care sector and has served on the Boards of Alcami Corporation since 2018, Solis Mammography since 2018, Performance Health since 2015, Advanced Personnel Management since 2020, Syntellis Performance Solutions since 2020, and Kaufman, Hall & Associates, LLC since 2014. Mr. Sullivan also serves on the Board of Managers of our largest stockholder, HC Group. Mr. Sullivan previously served on the Board of Ikaria, Inc. from 2014 to 2015, VWR Corporation, which became a publicly-traded company in 2014, from 2007 to 2017, Sage Products LLC from 2012 to 2016, and Sirona Dental Systems Inc. from 2005 to 2016, completing a reverse merger with publicly-traded Schick Technologies in 2005. Mr. Sullivan holds a B.S. from the United States Naval Academy, an M.S. from the University of Southern California and an M.B.A. from the Stanford University Graduate School of Business. Experience: Vice Chair (2024-Present), Co-Chief Executive Officer (2023-2024), Co-President (2022-2023) and Co-Founder, Managing Director, and Co-Head of Health Care (1992-2022) of MDP.
Background
Michael Bavaro, Chief Human Resources Officer (since March 2022) and Chief Diversity Officer (since August 2020); Responsible for leading our human resources and communications functions; Previously served as our Vice President of Human Resources (December 2015-March 2022); Past roles at Blue Cross and Blue Shield, Career Education Corporation and United Airlines; Active duty and reserve Navy veteran and retired Air Force Captain (as of January 2025); Holds a B.S. in Nuclear Engineering Technology from Thomas Edison State University and an M.B.A. from Keller Graduate School of Management at DeVry University.
Background
Dr. Femi Adewunmi, M.D., Chief Medical Officer (since April 2024); Responsible for our quality and clinical services, value-based care strategies and the use of data analytics to help enhance clinical outcomes and patient care, as well as providing oversight to our Naven Health organization More than 17 years of executive leadership experience managing healthcare operations, including at Carelon Health, Sound Physicians (a national provider of hospital-based physician services, post-acute services and value-based care), and UNC Health; 25 years of experience as a health care provider specializing in internal medicine and hospital medicine; Holds an M.D. in internal medicine from the University of Ibadan in Nigeria and an M.B.A. from the Fuqua School of Business at Duke University.
Background
Ms. Nicole Maggio currently serves as Senior Vice President, Corporate Controller and Principal Accounting Officer of the company.
From SEC filings, via Futu. Compensation is total reported pay for the most recent fiscal year on file, not base salary alone.
No comments yet — be the first to weigh in on OPCH.
Sign in to join the discussion.